(Q34431384)
Statements
1 reference
A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma (English)
1 reference
Kimura H
1 reference
Yamaguchi Y
1 reference
1 July 1997
1 reference
1 reference
80
1 reference
42-49
1 reference
Identifiers
1 reference